1,5-anhydroglucitol has been researched along with Cardiometabolic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, I; Ishikawa, F; Kato, A; Kunimatsu, T; Takeshita, K; Yamashita, Y | 1 |
1 other study(ies) available for 1,5-anhydroglucitol and Cardiometabolic Syndrome
Article | Year |
---|---|
Protective effects of dietary 1,5-anhydro-D-glucitol as a blood glucose regulator in diabetes and metabolic syndrome.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Glycosuria; Hyperglycemia; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL | 2013 |